These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36601048)
21. Prostate MRI quality: clinical impact of the PI-QUAL score in prostate cancer diagnostic work-up. Karanasios E; Caglic I; Zawaideh JP; Barrett T Br J Radiol; 2022 May; 95(1133):20211372. PubMed ID: 35179971 [TBL] [Abstract][Full Text] [Related]
22. Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program. Giganti F; Lindner S; Piper JW; Kasivisvanathan V; Emberton M; Moore CM; Allen C Eur Radiol Exp; 2021 Nov; 5(1):48. PubMed ID: 34738219 [TBL] [Abstract][Full Text] [Related]
23. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)? Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489 [TBL] [Abstract][Full Text] [Related]
24. Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy. Bianchi R; Cozzi G; Petralia G; Alessi S; Renne G; Bottero D; Brescia A; Cioffi A; Cordima G; Ferro M; Matei DV; Mazzoleni F; Musi G; Mistretta FA; Serino A; Tringali VML; Coman I; De Cobelli O Medicine (Baltimore); 2016 Oct; 95(40):e4519. PubMed ID: 27749525 [TBL] [Abstract][Full Text] [Related]
25. Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) score: A bicentric study. Girometti R; Blandino A; Zichichi C; Cicero G; Cereser L; De Martino M; Isola M; Zuiani C; Ficarra V; Valotto C; Bertolotto M; Giannarini G Eur J Radiol; 2022 May; 150():110267. PubMed ID: 35325773 [TBL] [Abstract][Full Text] [Related]
26. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235 [TBL] [Abstract][Full Text] [Related]
27. Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis. Mazzone E; Stabile A; Pellegrino F; Basile G; Cignoli D; Cirulli GO; Sorce G; Barletta F; Scuderi S; Bravi CA; Cucchiara V; Fossati N; Gandaglia G; Montorsi F; Briganti A Eur Urol Oncol; 2021 Oct; 4(5):697-713. PubMed ID: 33358543 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the accuracy of multiparametric magnetic resonance imaging (mpMRI) results with the final pathology findings for radical prostatectomy specimens in the detection of prostate cancer. Lee CH; Ku JY; Park WY; Lee NK; Ha HK Asia Pac J Clin Oncol; 2019 Apr; 15(2):e20-e27. PubMed ID: 29920966 [TBL] [Abstract][Full Text] [Related]
29. Is suspicious upstaging on multiparametric magnetic resonance imaging useful in improving the reliability of Prostate Cancer Research International Active Surveillance (PRIAS) criteria? Use of the K-CaP registry. Yoo S; Hong JH; Byun SS; Lee JY; Chung BH; Kim CS Urol Oncol; 2017 Jul; 35(7):459.e7-459.e13. PubMed ID: 28476529 [TBL] [Abstract][Full Text] [Related]
30. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit. Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844 [TBL] [Abstract][Full Text] [Related]
31. Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease? Kim H; Pak S; Park KJ; Kim MH; Kim JK; Kim M; You D; Jeong IG; Song C; Hong JH; Kim CS; Ahn H Clin Genitourin Cancer; 2020 Feb; 18(1):50-55. PubMed ID: 31640913 [TBL] [Abstract][Full Text] [Related]
32. Inter-reader agreement of the prostate imaging quality (PI-QUAL) score for basic readers in prostate MRI: A multi-center study. Basar Y; Alis D; Seker ME; Kartal MS; Guroz B; Arslan A; Sirolu S; Kurtcan S; Denizoglu N; Karaarslan E Eur J Radiol; 2023 Aug; 165():110923. PubMed ID: 37320883 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men. Russo F; Mazzetti S; Regge D; Ambrosini I; Giannini V; Manfredi M; De Luca S; Bollito E; Porpiglia F Eur Urol Oncol; 2021 Dec; 4(6):855-862. PubMed ID: 33893066 [TBL] [Abstract][Full Text] [Related]
34. MR image quality in local staging of prostate cancer: Role of PI-QUAL in the detection of extraprostatic extension. Ponsiglione A; Stanzione A; Califano G; De Giorgi M; Collà Ruvolo C; D'Iglio I; Morra S; Longo N; Imbriaco M; Cuocolo R Eur J Radiol; 2023 Sep; 166():110973. PubMed ID: 37453275 [TBL] [Abstract][Full Text] [Related]
35. Role of multiparametric magnetic resonance imaging to predict postoperative Gleason score upgrading in prostate cancer with Gleason score 3 + 4. Kim H; Kim JK; Hong SK; Jeong CW; Ku JH; Kwak C World J Urol; 2021 Jun; 39(6):1825-1830. PubMed ID: 32869150 [TBL] [Abstract][Full Text] [Related]
36. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy. Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971 [TBL] [Abstract][Full Text] [Related]
37. Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients? Roscigno M; Stabile A; Lughezzani G; Pepe P; Dell'Atti L; Naselli A; Naspro R; Nicolai M; La Croce G; Muhannad A; Perugini G; Guazzoni G; Montorsi F; Balzarini L; Sironi S; Da Pozzo LF Prostate Int; 2020 Dec; 8(4):167-172. PubMed ID: 33425794 [TBL] [Abstract][Full Text] [Related]
38. A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomy. Castellani D; Cecchini S; Mazzucchelli R; Soraci L; Di Rosa M; Fabbietti P; Palagonia E; Puccio F; Carnevali F; Paci E; Montironi R; Galosi AB Urol Oncol; 2022 Aug; 40(8):379.e1-379.e8. PubMed ID: 35662497 [TBL] [Abstract][Full Text] [Related]
39. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies. Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169 [TBL] [Abstract][Full Text] [Related]
40. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy. Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]